Targeting intrinsic apoptosis rewires human NK cell persistence: NOXA as a dominant survival switch
Molecular Therapy Oncology · 2026-06 · 34 (2) · 201212
DOI: 10.1016/j.omton.2026.201212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Oncology, 2026-06. Verfasst von David Perea Pérez und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Galway Cancer Centre, Lambe Institute for Translational Research, School of Medicine, College of Medicine, Nursing and Health Sciences,…. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Despite potent cytotoxic capacity, natural killer (NK) cell-based therapies have been consistently limited by poor persistence following adoptive transfer, with most studies reporting an inability to detect infused NK cells beyond 1–4 weeks.1 This lack of durability is particularly problematic in solid tumors such as pancreatic ductal adenocarcinoma (PDAC), where sustained effector function is required to overcome a profoundly suppressive tumor microenvironment (TME). Current strategies to address this limitation have largely focused on cytokine support, most notably through IL-15 supplementation or genetic engineering approaches, yet persistence remains suboptimal.
Autor:innen und Institutionen
- University of Galway Cancer Centre, Lambe Institute for Translational Research, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
- Discipline of Medicine, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
Zitieren
APA
Pérez, D. P., & O'Dwyer, M. E. (2026). Targeting intrinsic apoptosis rewires human NK cell persistence: NOXA as a dominant survival switch. Molecular Therapy Oncology, 34(2), 201212. https://doi.org/10.1016/j.omton.2026.201212
Vancouver
Pérez DP, O'Dwyer ME. Targeting intrinsic apoptosis rewires human NK cell persistence: NOXA as a dominant survival switch. Molecular Therapy Oncology. 2026;34(2):201212. doi:10.1016/j.omton.2026.201212
BibTeX
@article{Prez2026,
author = {Pérez, David Perea and O'Dwyer, Michael E},
title = {Targeting intrinsic apoptosis rewires human NK cell persistence: NOXA as a dominant survival switch},
journal = {Molecular Therapy Oncology},
year = {2026},
volume = {34},
number = {2},
pages = {201212},
doi = {10.1016/j.omton.2026.201212}
}
EUVIMED